IDEAYA Biosciences, Inc. financial data

Symbol
IDYA on Nasdaq
Location
5000 Shoreline Ct, Suite 300, South San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.33K % -38.5%
Debt-to-equity 7.65 % +80%
Return On Equity -15.6 % +19.9%
Return On Assets -14.4 % +22.5%
Operating Margin -4.67K % -713%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 87.7M shares +1.43%
Common Stock, Shares, Outstanding 87.7M shares +1.52%
Entity Public Float 2.7B USD +108%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 88.5M shares +2.71%
Weighted Average Number of Shares Outstanding, Diluted 89.7M shares +4.06%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 208M USD
Research and Development Expense 368M USD +90.6%
General and Administrative Expense 55.4M USD +56.5%
Operating Income (Loss) -209M USD +7.06%
Nonoperating Income (Expense) 48.1M USD +3.24%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -161M USD +9.76%
Earnings Per Share, Basic -1 USD/shares +18.1%
Earnings Per Share, Diluted -1 USD/shares +17.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 299M USD -25.3%
Marketable Securities, Current 488M USD -6.11%
Assets, Current 803M USD -13.9%
Property, Plant and Equipment, Net 8.17M USD -0.77%
Operating Lease, Right-of-Use Asset 23.5M USD +28.1%
Other Assets, Noncurrent 75K USD -30.6%
Assets 1.19B USD -4.42%
Accounts Payable, Current 18.4M USD +46.7%
Employee-related Liabilities, Current 9.38M USD +26.2%
Accrued Liabilities, Current 45.3M USD +61.1%
Contract with Customer, Liability, Current 490K USD
Liabilities, Current 64.5M USD +58.7%
Contract with Customer, Liability, Noncurrent 1.68M USD
Operating Lease, Liability, Noncurrent 26.9M USD +43.2%
Liabilities 93.1M USD +56.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 2.05M USD -46.5%
Retained Earnings (Accumulated Deficit) -653M USD -32.6%
Stockholders' Equity Attributable to Parent 1.09B USD -7.49%
Liabilities and Equity 1.19B USD -4.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -60.3M USD -37.7%
Net Cash Provided by (Used in) Financing Activities 26.1M USD -92.5%
Net Cash Provided by (Used in) Investing Activities 79.8M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 87.7M shares +1.52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 45.6M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 300M USD -25.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -7.69%
Deferred Tax Assets, Valuation Allowance 165M USD +71.9%
Deferred Tax Assets, Gross 169M USD +75%
Operating Lease, Liability 27.2M USD +45%
Payments to Acquire Property, Plant, and Equipment 1.33M USD +0.38%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -163M USD +6.35%
Lessee, Operating Lease, Liability, to be Paid 46.5M USD +22.7%
Property, Plant and Equipment, Gross 21.9M USD +12.8%
Operating Lease, Liability, Current 328K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.38M USD +99.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.94M USD +404%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -15.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19.2M USD +0.81%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.25M USD +18.6%
Deferred Tax Assets, Operating Loss Carryforwards 37.5M USD +8.09%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.93M USD +55.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.32M USD +25%
Operating Lease, Payments 100K USD -80%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 600K USD -2.6%
Deferred Tax Assets, Net of Valuation Allowance 4.1M USD +531%
Share-based Payment Arrangement, Expense 43.8M USD +45.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%